# Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab

> **NCT01299857** · PHASE3 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 22 (actual)

## Conditions studied

- Pemphigus

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT01299857
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-06
- **Final completion:** 2012-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01299857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01299857, "Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01299857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*